Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.64 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.34 |
| ▸ | GRM8 | O00222 | 1/20 | 0.34 |
| ▸ | GRM6 | O15303 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Penicillamine SCHEMBL7170074 | 1.00 | PTGS1 (0.72) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Dl-Penicillamine SCHEMBL4261009 | 1.00 | PTGS1 (0.72) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Penicillamine SCHEMBL22124996 | 1.00 | PTGS1 (0.72) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Penicillamine SCHEMBL11222229 | 0.98 | PTGS1 (0.69) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Dl-Penicillamine SCHEMBL159653 | 0.85 | ALDH1A1 (1.00) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Dl-Penicillamine SCHEMBL22322162 | 0.85 | ALDH1A1 (1.00) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Dl-Penicillamine SCHEMBL4344 | 0.85 | — | — | |
| Dl-Penicillamine SCHEMBL57527 | 0.85 | — | — | |
| Penicillamine SCHEMBL129296 | 0.85 | ALDH1A1 (1.00) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 | |
| Penicillamine SCHEMBL603349 | 0.85 | ALDH1A1 (1.00) | PTGS1ALDH1A1MAPTSLC7A11SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041217-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | Blackhawk Partners Ltd. (CY) | 2022-08-17 | — | — | EP | claimed |
| WO-2021198041-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE, CHLOROQUINE, OR METABOLITE THEREOF | BLACKHAWK PARTNERS LIMITED (CY) | 2021-10-07 | — | — | WO | claimed |
| WO-2021069576-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | BLACKHAWK PARTNERS LTD (CY) | 2021-04-15 | — | — | WO | claimed |
| US-20230100385-A1 | Pharmaceutical Composition Comprising Cannabinoid | BLACKHAWK PARTNERS LTD (CY) | 2023-03-30 | — | — | US | disclosed |
| EP-4041217-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | Blackhawk Partners Ltd. (CY) | 2022-08-17 | — | — | EP | disclosed |
| EP-4041217-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | Blackhawk Partners Ltd. (CY) | 2022-08-17 | — | — | EP | disclosed |
| EP-3897849-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | BicycleTx Limited (GB) | 2021-10-27 | — | — | EP | disclosed |
| WO-2021198041-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE, CHLOROQUINE, OR METABOLITE THEREOF | BLACKHAWK PARTNERS LIMITED (CY) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021198041-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE, CHLOROQUINE, OR METABOLITE THEREOF | BLACKHAWK PARTNERS LIMITED (CY) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021069576-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | BLACKHAWK PARTNERS LTD (CY) | 2021-04-15 | — | — | WO | disclosed |
| WO-2021069576-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | BLACKHAWK PARTNERS LTD (CY) | 2021-04-15 | — | — | WO | disclosed |
| US-20210106636-A1 | PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | BLACKHAWK PARTNERS LTD (CY) | 2021-04-15 | — | — | US | disclosed |
| WO-2020128526-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | BICYCLETX LIMITED (GB) | 2020-06-25 | — | — | WO | disclosed |
| CN-1835740-A | Pharmaceutical composition for preventing breast cancer and ovarian cancer | POMERANIAN ACADEMY OF MEDICINE (PL) | 2006-09-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100385-A1 | Pharmaceutical Composition Comprising Cannabinoid | CNR2, CNR1, GSR | PTGS1 107/4885ALDH1A1 1591/4885MAPT 819/4885 |
| US-20210106636-A1 | PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID | CNR2, CNR1, GSR | PTGS1 107/4885ALDH1A1 1591/4885MAPT 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.